Bharat Biotech

Covaxin Manufacturer's 'Excellent Safety Record' Message Amid Covishield Row Over 'Side-Effects'

India Launches Bharat Biotech's iNCOVACC, World's First Intranasal Covid-19 Vaccine: All About It

Bharat Biotech's Intranasal Covid Vaccine Priced At Rs 325 In Govt Hospitals, Rs 800 In Private

Bharat Biotech's Nasal Vaccine Rolls Out Today Amid Covid Scare. All You Need To Know

Bharat Biotech's Nasal COVID Vaccine Receives Govt Nod For Use As Heterologous Booster In Adults

Bharat Biotech Condemns 'Targetted Narrative' Against Covaxin, Denies Any ‘Political Pressure’ During Covid-19 Vaccine Development

50 Million Doses Of Covaxin Set To Expire Early 2023 Due To Poor Off Take: Report

Bharat Biotech's Intranasal Covid-19 Vaccine Will Be A Global Gamechanger: Chairman Krishna Ella

Explained: As Govt Clears Bharat Biotech's Nasal Covid-19 Vaccine, Know How It Works

Bharat Biotech's Intranasal Covid-19 Vaccine Cleared For Emergency Use In Adults

Nigeria Introduces Bharat Biotech’s Rotavac Vaccine For Immunisation In Children

Bharat Biotech's Intranasal Covid Vaccine BBV154 Proven 'Safe, Well-Tolerated And Immunogenic' In Phase III Trials